Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 575Neoplasms 470Lung Neoplasms 303Colorectal Neoplasms 297Carcinoma, Non-Small-Cell Lung 219Stomach Neoplasms 215Carcinoma, Hepatocellular 204Prostatic Neoplasms 183Pancreatic Neoplasms 156Ovarian Neoplasms 143Uterine Cervical Neoplasms 128Colonic Neoplasms 122Rectal Neoplasms 113Urinary Bladder Neoplasms 100Neoplasm Metastasis 95Esophageal Neoplasms 90Endometrial Neoplasms 86Head and Neck Neoplasms 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Leukemia, Myeloid, Acute 79Brain Neoplasms 69Recurrence 68Melanoma 66Disease 65Liver Neoplasms 60Multiple Myeloma 59Lymphoma 59Glioma 58Squamous Cell Carcinoma of Head and Neck 54Polycystic Ovary Syndrome 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Observational × Chemotherapy-induced Thrombocytopenia × Clear all
NCT03049774 2017-02-10

A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Angde Biotech Pharmaceutical Co., Ltd.

Unknown
2,000 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡